Medically Reviewed By:
Written By:
Last Modified April 29, 2022
This page features 12 Cited Research Articles
Fact Checked
Our fact-checking process begins with a thorough review of all sources to ensure they are high quality. Then we cross-check the facts with original medical or scientific reports published by those sources, or we validate the facts with reputable news organizations, medical and scientific experts and other health experts. Each page includes all sources for full transparency.
Reviewed is the nation’s most trusted mesothelioma resource

The Mesothelioma Center at has provided patients and their loved ones the most updated and reliable information on mesothelioma and asbestos exposure since 2006.

Our team of Patient Advocates includes a medical doctor, a registered nurse, health services administrators, veterans, VA-accredited Claims Agents, an oncology patient navigator and hospice care expert. Their combined expertise means we help any mesothelioma patient or loved one through every step of their cancer journey.

More than 30 contributors, including mesothelioma doctors, survivors, health care professionals and other experts, have peer-reviewed our website and written unique research-driven articles to ensure you get the highest-quality medical and health information.

About The Mesothelioma Center at

  • Assisting mesothelioma patients and their loved ones since 2006.
  • Helps more than 50% of mesothelioma patients diagnosed annually in the U.S.
  • A+ rating from the Better Business Bureau.
  • 5-star reviewed mesothelioma and support organization.
Learn More About Us


"My family has only the highest compliment for the assistance and support that we received from The Mesothelioma Center. This is a staff of compassionate and knowledgeable individuals who respect what your family is experiencing and who go the extra mile to make an unfortunate diagnosis less stressful. Information and assistance were provided by The Mesothelioma Center at no cost to our family."
Mesothelioma patient’s daughter
  • Google Review Rating
  • BBB Review Rating
Read Our Testimonials

What is Photofrin?

In clinical trials, researchers found that this treatment can improve life expectancy in pleural mesothelioma patients, especially when used in combination with other treatments such as surgery.

The main photosensitizer used for pleural mesothelioma treatment is porfimer sodium, usually called Photofrin. The Food and Drug Administration (FDA) approved this drug for use in other cancers, such as esophageal cancer, and recognized its potential in treating mesothelioma.

Because Photofrin may help treat the rare cancer, the FDA designated it an orphan drug, which helps speed along the FDA approval process.

How Does Photodynamic Therapy Work?

Photodynamic therapy is administered during surgery, when the chest cavity has been entered and the tumors can be directly exposed to the lasers. It may be used in conjunction with other treatments, such as chemotherapy and surgery, to fight the cancer in multiple ways.

The treatment begins with the administration of a photosensitizing agent, which is injected into the bloodstream before surgery. This drug is absorbed by cells, both healthy and cancerous, but stays in cancerous cells longer. After one to three days, the photosensitizer has left most healthy cells but remains in mesothelioma cells. This is when light is administered during surgery, usually via laser, to activate the photosensitizer.

This light must be at a specific wavelength and color in order to trigger a reaction within the drug. Photofrin, for example, reacts to red light. Once the drug is activated, it produces a highly reactive form of oxygen. The oxygen affects all nearby cancer cells, prompting them to die. It may also damage the tumor’s blood vessels, thus cutting off the nutrient supply and killing cancer cells.

Which Patients Are Eligible?

Photodynamic therapy can only be used on areas of the body that light can reach, such as just below the skin or along the lining of internal organs. In the case of mesothelioma, this means that it is used during surgery when the tumors are exposed. Because of this, the therapy is most effective in treating localized cancer that has not spread throughout the body. In addition, individuals with large tumors may not be suitable candidates for this therapy, as the light is unable to penetrate the entire tumor.

Find a Mesothelioma Cancer Center
Access top mesothelioma cancer centers that have experience treating this rare disease.

Side Effects of Photodynamic Therapy

This treatment causes skin and eye sensitivity to light for about six weeks. Doctors advise patients to avoid sunlight and other bright light during this time. PDT may cause swelling, burning, pain or scarring in healthy tissues. Patients may also experience coughing, trouble swallowing, stomach pain, painful breathing or shortness of breath.

Study Results

Studies of photodynamic therapy in pleural mesothelioma patients have been successful in recent years, but some early studies showed no improvement when PDT was used. In a 1996 study, 63 pleural mesothelioma patients underwent surgery and chemotherapy, and half were randomly selected to receive PDT as well. Based on the addition of PDT, researchers found no significant difference in survival times. Patients lived a median of 14.1 months without PDT and 14.4 months with it.

A 2004 study showed a substantial improvement in survival times when photodynamic therapy was added to surgery. Patients treated with surgery alone lived a median of 10 months, while patients treated with surgery and PDT survived a median of 13 to 14 months. Researchers concluded that the therapy showed promise in successfully treating mesothelioma and must be studied further.

A 2019 study published in the journal Photochemistry and Photobiology reported on the safety and outcomes of combining photodynamic therapy with proton radiation therapy and chemotherapy. Ten patients were included in the study, and all of them were diagnosed with stage 3 or 4 pleural mesothelioma. Median survival was 30.3 months, which is a significant improvement from the average life expectancy of 12 months.

A Canadia research team published their findings in 2021 about the potential of photodynamic therapy to treat metastatic disease in mesothelioma patients. The new approach uses immunotherapy combined with photodynamic therapy to shrink tumors throughout the body. In multimodal combination therapy with other treatments, a systemic immune response could improve outcomes for metastatic mesothelioma patients.

Where Is Photodynamic Therapy for Mesothelioma Available?

Encouraging clinical trial results have led some of the country’s top cancer centers to offer photodynamic therapy to their patients. The Abramson Cancer Center in Pennsylvania and the Stanford Cancer Institute in California have this therapy available for mesothelioma patients who qualify for it. Brigham and Women’s Hospital, renowned for its mesothelioma program, is also equipped for PDT but does not normally use it in mesothelioma treatment.

Future of Photodynamic Therapy

Medical researchers seek to improve the efficacy of PDT and use it in more types of cancer, including peritoneal mesothelioma. Researchers hope to develop photosensitizers that specifically target cancer cells and have more toxic reactions. Doctors also hope to find a more effective means of administering the necessary light so that it can penetrate tissue and treat larger tumors.

Mesothelioma packet from the Mesothelioma Center
Get Your Free Mesothelioma Treatment Guide
Laptop with screen video conference on kitchen counter
Watch Our Free Mesothelioma Webinars
Technician documenting notes in a lab
Find Active Mesothelioma Clinical Trials

Tell us what you think
Did this article help you?
How did this article help you?
What about this article isn’t helpful for you?
Did this article help you?

Thank you for your feedback. Would you like to speak with a Patient Advocate?